Skip to main content
See every side of every news story
Published loading...Updated

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

  • Viatris Inc. is the subject of a class action lawsuit accusing the company of securities fraud connected to FDA warnings issued about its Indore, India manufacturing site during a specified period from mid-2024 to early 2025.
  • The suit arises after defendants disclosed the FDA's warning letter and import alert months following a failed inspection and remediation efforts at the facility.
  • Defendants described the warning's impact as a 'minor headwind' but allegedly concealed material facts that affected Viatris' financial condition and misled investors.
  • Investors who bought Viatris securities on NASDAQ during the Class Period may seek compensation without upfront costs by moving for lead plaintiff status by June 3, 2025.
  • The Rosen Law Firm, representing global investors, has a record of multi-hundred-million-dollar recoveries, including over $438 million secured in 2019 for clients.
Insights by Ground AI

149 Articles

Bennington BannerBennington Banner
+143 Reposted by 143 other sources
Center

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit

NEW YORK, April 15, 2025 /PRNewswire/ -

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Tuesday, April 15, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal